MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer

Eralp, Y.; Derin, D.; Ozluk, MESUDE; Yavuz, Erdem; Guney, N.; Saip, P.; Muslumanoglu, M.; Igci, A.; Kucucuk, S.; Dincer, M.; Aydiner, A.; Topuz, E.

doi:10.1093/annonc/mdm522

MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer

Eralp Y., Derin D., Ozluk Y., Yavuz E., Guney N., Saip P., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.19, sa.4, ss.669-674, 2008 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 4
Basım Tarihi: 2008
Doi Numarası: 10.1093/annonc/mdm522
Dergi Adı: ANNALS OF ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.669-674
Anahtar Kelimeler: chemoresistance, EGFR, MAPK, prognosis, triple-negative breast cancer, ACTIVATED PROTEIN-KINASE, BASAL-LIKE SUBTYPE, PROGNOSTIC-SIGNIFICANCE, EXPRESSION PATTERNS, CARCINOMAS, PHENOTYPE, RECEPTOR, PATHWAYS, SURVIVAL
İstanbul Üniversitesi Adresli: Evet

Özet

Background: Triple-negative breast cancer is estimated to account for 15%-20% of all patients with breast cancer and is considered as a prognostically unfavorable subset. The aim of this study is to evaluate the prognostic impact of various molecular factors in patients with triple-negative breast cancer.